tradingkey.logo
tradingkey.logo
Search

Artivion Inc

AORT
Add to Watchlist
23.970USD
+0.420+1.78%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.16BMarket Cap
93.41P/E TTM

More Details of Artivion Inc Company

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Info

Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMackin (James Patrick)
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMackin (James Patrick)

Company Executives of Artivion Inc

Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

FAQs

Who are the top five shareholders of Artivion Inc?

The top five shareholders of Artivion Inc are: Mr. John E. Davis

How many institutions hold shares of Artivion Inc (AORT)?

As of 2026Q1, 449 institutions hold shares of Artivion Inc, with a combined market value of approximately 45.29M, accounting for 93.40% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 501666.00.

What is the biggest source of revenue for Artivion Inc?

In 2026Q1, the Aortic stent grafts business generated the highest revenue for Artivion Inc, amounting to 159.37M and accounting for 36.11% of total revenue.